Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study

Fig. 1

Patient disposition. csDMARD, conventional synthetic disease-modifying anti-rheumatic drug; HR-pQCT, high-resolution peripheral quantitative computed tomography

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us